Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2021
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 TrialConor E Steuer, Opeyemi A Jegede, Suzanne E Dahlberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730)Rogerio C Lilenbaum, James E Herndon, Marcy A List, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete ResectionMing-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.Annals of Surgical Oncology|October 28, 2022
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)M Margaret Kemeny, Fengmin Zhao, Arlene A Forastiere, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2018
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung CancerSiddhartha Devarakonda, Federico Rotolo, Ming-Sound Tsao, et al.Journal of the National Cancer Institute|April 20, 2001
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancerS M Lippman, J J Lee, D D Karp, et al.The Lancet. Oncology|November 14, 2017
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trialHeather A Wakelee, Suzanne E Dahlberg, Steven M Keller, et al.Pageof 8